HOME
ABOUT
OUR COMPANY
BOARD
ADVISORY BOARD
LOCATIONS
MEDICAL CANNABIS
SCIENCE
LEGALISED MARKETS
RESEARCH
PRODUCT PIPELINE
PRECLINICAL
PANCREATIC CANCER
BREAST CANCER
BRAIN CANCER
DIABETES RELATED COGNITIVE DECLINE
CLINICAL TRIALS
AUTISM
INSOMNIA
CHRONIC PAIN
PRODUCTS
Doctors
Pharmacists
Patients
INVESTORS
ASX ANNOUNCEMENTS
2021
2020
2019
2018
2017
2016
PRESENTATIONS & VIDEOS
2021
2020
2019
2018
2017
2016
2015
REPORTS
STOCK INFORMATION
CORPORATE GOVERNANCE
MEDIA
VIDEOS & AUDIOS
ARTICLES
Autism Symposium
CONTACT
HOME
ABOUT
- OUR COMPANY
- BOARD
- ADVISORY BOARD
- LOCATIONS
- MEDICAL CANNABIS
- SCIENCE
- LEGALISED MARKETS
RESEARCH
- PRODUCT PIPELINE
- PRECLINICAL
- PANCREATIC CANCER
- BREAST CANCER
- BRAIN CANCER
- DIABETES RELATED COGNITIVE DECLINE
- CLINICAL TRIALS
- AUTISM
- INSOMNIA
- CHRONIC PAIN
PRODUCTS
- Doctors
- Pharmacists
- Patients
INVESTORS
- ASX ANNOUNCEMENTS
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- PRESENTATIONS & VIDEOS
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- REPORTS
- STOCK INFORMATION
- CORPORATE GOVERNANCE
MEDIA
- VIDEOS & AUDIOS
- ARTICLES
- Autism Symposium
CONTACT
Zelda Therapeutics debuts on ASX
By
Zelira Therapeutics
November 22, 2016
articles-2016
Zelda Therapeutics debuts on ASX
Investor Presentation – Nov 2016
Zelda Expands Intellectual Property Portfolio